Key developments include approvals for complex injectables like iron sucrose and liraglutide and progress in Phase 3 trials ...

Amneal Pharmaceuticals and Shilpa Medicare have launched the new presentation of bortezomib, Boruzu, for subcutaneous or ...

acid (PLGA), a biocompatible polymer and its application in the development of long-acting injectables (LAI) with insight into the development of in vitro-in vivo correlations (IVIVCs) and in vitro-in ...

The approval marks another milestone in Biocon’s strategy to diversify its pharmaceutical offerings and expand its presence in regulated markets, particularly in the complex injectables segment.

Indian pharma players have been witnessing reprieve from price erosion and US product launches in the past few quarters. A ...